Study uncovers how APOBEC enzymes drive cancer mutations

A research team led by the University of California, Irvine has discovered the key role that the APOBEC3A and APOBEC3B enzymes play in driving cancer mutations by modifying the DNA in tumor genomes, offering potential new targets for intervention strategies.

Immunic to Participate in Industry, Scientific and Investor Conferences in November – Biotech Investments

Issuer: Immunic AG / Key word(s): Conference 29.10.2024 / 11:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate

October 30, 2024

What to watch at ESMO: readouts from trials in lung, prostate, and other types of cancer

Europe’s major cancer research conference kicks off in Madrid on Friday, with headline — and potentially practice-changing — readouts from trials in lung, prostate, and

October 19, 2023

Edible flowers bloom with health benefits

Study analyzes the bioactive compounds, antioxidant activities, and aroma profiles of four edible flowers, contributing to their nutritional and health value understanding.

March 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.